Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Oscient Pharmaceuticals (Antara Drug)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

A cholesterol-lowering medicine. The drug is engaged in lowering the cholesterol level in patients. It has the generic name fenofibrate.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • 1000 Winter Street
  • Suite 2200
  • Waltham, MA 02451
  • United States

Oscient Pharmaceuticals (Antara Drug) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Oscient Pharmaceuticals (Antara Drug)‘s full profile, request access.

Request full access to PitchBook

Oscient Pharmaceuticals (Antara Drug) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Oscient Pharmaceuticals (Antara Drug)‘s full profile, request access.

Request full access to PitchBook